Evidence map›Paper›PMID 40310531›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

Germany in pharmacology publishing: 192 articles with 1367 citations in Naunyn-Schmiedeberg's Archives vs. 16,775 articles with 274,225 citations elsewhere.

Siddig Ibrahim Abdelwahab, Abdullah Farasani, Jobran M Moshi, Saeed Alshahrani, Waseem Hassan

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Siddig Ibrahim AbdelwahabHealth Research Center, Jazan University, Jazan, Saudi Arabia.
Abdullah FarasaniDepartment of Medical Laboratory Technology, Faculty of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia.
Jobran M MoshiDepartment of Medical Laboratory Technology, Faculty of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia.
Saeed AlshahraniDepartment of Pharmacology and Toxicology, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
Waseem HassanInstitute of Chemical Sciences, University of Peshawar, Peshawar, 25120, Khyber Pakhtunkhwa, Pakistan. waseem_anw@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Germany has played a central role in the development of Naunyn-Schmiedeberg's Archives of Pharmacology (NSAP), historically leading its publication output for nearly 150 years. However, recent bibliometric analysis of 25,935 articles revealed a dramatic decline in German contributions, with the country falling to fifth place between 2021 and 2025. To understand this shift, we conducted a comprehensive bibliometric study of 28,149 pharmacology- and toxicology-related publications from German institutions indexed in Scopus between 2019 and 2024. Our findings indicate a strong trend toward publishing in high-impact journals: 61% of the publications appeared in Q1 journals and 28% in Q2. Although NSAP ranked 28th in publication volume, the vast majority of German research-over 16,700 articles-was disseminated through other venues, many with significantly higher citation metrics. These shifts highlight the growing influence of bibliometric indicators on publication behavior. While such trends reflect global academic pressures, they also prompt a critical reflection on the value of legacy journals. We advocate for renewed institutional support and national awareness to maintain NSAP as a respected platform for pharmacological research, balancing impact metrics with scientific heritage.

Indexed as

BibliometricsPeriodicals as TopicPharmacologyPublishingGermanyHumansJournal Impact FactorGermanyJournal metricsPharmacology researchPublications

Identifiers

PMID40310531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.